|
|
 |
|
Viewing report
|
|
|
|
Functional Genomics: Turning Promise into Profits
Drug and Market Development Publishing, Sep 2002, Pages: 270
It is time to deliver on the promise of the human genome some companies are closer than others.
Incredible strides have been made over the last few years sequencing the human genome. Now the focus has shifted from the collection of sequence data to the analysis of gene function, both in health and in disease. As new information unfolds, companies scramble to turn the promise of these codes into commercial products aimed at treating diseases that were previously untreatable.
This rapidly evolving industry has left the competitive landscape almost unrecognizable. Over the last two years alone some private companies have gone public, others have failed, existing companies have changed focus and still others have joined the field.
D&MD's Market Analysis Report Functional Genomics: Turning Promise Into Profits uncovers the strategies and focus shifts for the leading companies as well as highlights the most significant developments in applications driving this industry forward.
This Report Will:
Look at the big picture with an overview of Genomics, including the technologies and development strategies leading to todayís genomic sciences.
Focus on next steps with discussion of the impact of the Human Genome Project on the Genomics field.
Highlight the applications of DNA as therapeutics with coverage of gene therapy, antisense therapeutics, and Single Nucleotide Polymorphism (SNP).
Uncover the politics with an analysis of legal and ethical issues surrounding gene patenting and genetic testing.
Keep an eye on the leaders in the field with over 30 in-depth company profiles outlining the business focus, research and development pipelines, and financials of each.
Update your competitive files with brief profiles of over 70 additional genomics-associated companies.
Customers who bought this item also bought
Systems Biology - Key to Unlocking the Value within the Omics Revolution
Novel Targets in Drug Discovery
Has Genomics Failed to Deliver?
Gene Therapy: Current Status and Prospects
The Transgenic Plant Market: Profits from New Products and Novel Drugs
The Future of the With Profits market
UK With-Profits 2005
Gene Therapy - Global Strategic Business Report
|
|
|
|
